Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-015141
Filing Date
2025-06-02
Accepted
2025-06-02 16:26:59
Documents
2
Period of Report
2025-06-02

Document Format Files

Seq Description Document Type Size
1 form3-06022025_080656.html 3  
1 form3-06022025_080656.xml 3 1702
2 ex24-06022025_080600.htm EX-24 7103
  Complete submission text file 0001415889-25-015141.txt   10330
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O APTOSE BIOSCIENCES INC. 251 CONSUMERS ROAD, SUITE 1105 TORONTO A6 M2J 4R3
Business Address
Chow Gregory K. (Reporting) CIK: 0001761333 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38662 | Film No.: 251015351